Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Heterogeneous nuclear ribonucleoprotein R pseudogene 1 (HNRNPRP1) is annotated in genomic databases as a processed or duplicated pseudogene derivative of the HNRNPR gene, which encodes an RNA-binding protein involved in mRNA splicing and transport. Unlike its parental protein-coding gene, HNRNPRP1 does not produce a functional protein product and lacks direct molecular functions, disease associations, or known drug interactions. Pseudogenes like HNRNPRP1 may have regulatory effects at the RNA level in some contexts, but there is no direct evidence for such roles or relevance in therapeutic targeting. In summary, "HNRNPRP1" should not be considered a canonical therapeutic target, and its identification as such represents either a misinterpretation or a database artifact.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein R pseudogene 1.